Abstract

Foundation models, characterized by their unparalleled ability to process and synthesize vast and diverse datasets, have rapidly emerged as a profoundly transformative force within the landscape of artificial intelligence (AI), particularly demonstrating immense promise and impact within the healthcare sector. These sophisticated models, epitomized by cutting-edge solutions like Aidoc’s CARE™ (Clinical AI Reasoning Engine), are meticulously trained on expansive multimodal data sources, encompassing everything from high-resolution medical images and granular electronic health records (EHRs) to complex genomic sequences. This comprehensive pre-training paradigm enables their rapid adaptation and deployment across a remarkably broad spectrum of clinical domains, significantly accelerating the development of specialized applications.

This research report embarks on an in-depth exploration of the fundamental architectural principles underpinning foundation models, elucidating their unique and compelling advantages within healthcare. Crucially, it also critically examines the multifaceted challenges inherently associated with their successful and responsible deployment in highly regulated and sensitive clinical settings. By meticulously dissecting their integration capabilities with cornerstone healthcare data modalities such as electronic health records, advanced medical imaging, and intricate genomic data, the report aims to furnish a holistic and contemporary overview of the current operational landscape and delineate the burgeoning future prospects of foundation models in revolutionizing healthcare delivery. Special attention is paid to how these models contribute to enhanced diagnostic precision, accelerated clinical innovation, and the eventual realization of truly personalized medicine, all while navigating critical considerations of data governance, ethical implications, and computational resource demands.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

1. Introduction

The advent and progressive integration of artificial intelligence (AI) into the fabric of healthcare have heralded a period of unprecedented advancements across numerous facets of medical practice, profoundly impacting diagnostics, refining treatment planning methodologies, and elevating the overall standard of patient care. Historically, AI models developed for healthcare were predominantly task-specific, meticulously engineered and trained to address singular, well-defined problems such as the detection of a particular lesion type in an MRI scan or the prediction of readmission risk for a specific patient cohort. While undeniably valuable, this conventional approach often led to siloed applications, demanding significant resources for each new problem and struggling with generalization across diverse clinical scenarios or varied data distributions.

This paradigm has begun to shift dramatically with the emergence of a new generation of AI systems: foundation models. Unlike their predecessors, foundation models are distinguished by their vast scale, their training on extraordinarily extensive and diverse datasets—often encompassing terabytes or even petabytes of information—and their capacity to perform a wide array of downstream tasks without needing to be trained from scratch for each specific application. They embody a ‘learn-then-adapt’ paradigm, where broad pre-training on general data enables powerful transfer learning capabilities to specialized domains. This adaptability stems from their ability to learn rich, generalized representations of data, which can then be rapidly fine-tuned for specific clinical objectives with comparatively smaller, task-specific datasets.

Within healthcare, these models are trained on an eclectic mix of data types, ranging from high-resolution medical images (e.g., CT, MRI, X-ray) and comprehensive electronic health records (EHRs) containing clinical notes, lab results, and medication lists, to intricate genomic and proteomic information. This multimodal training allows them to develop a holistic understanding of patient health, enabling them to generalize across multiple diseases, conditions, and patient populations. A pioneering example of this transformative shift is the development of Aidoc’s CARE™ (Clinical AI Reasoning Engine) model. CARE™ stands as a testament to the potential of clinical-grade foundation models, serving as a robust platform capable of powering multiple FDA-cleared applications and facilitating the agile and rapid development of new, high-impact clinical AI solutions. Its unique position as a foundational layer for numerous AI applications underscores its strategic importance in democratizing access to advanced AI capabilities within complex clinical environments and accelerating the journey towards more efficient, accurate, and personalized healthcare delivery.

This report will comprehensively analyze the intricate architectural underpinnings of these models, dissect their compelling advantages, and meticulously address the formidable challenges associated with their pragmatic and ethical deployment within the highly regulated and sensitive clinical environments, ultimately charting a course for their responsible integration into the future of medicine.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

2. Architectural Principles of Foundation Models

Foundation models represent a significant leap in AI architecture, differing fundamentally from previous generations of models in their scale, pre-training methodologies, and emergent capabilities. Understanding their underlying principles is crucial to appreciating their transformative potential in healthcare.

2.1 Definition and Characteristics

A foundation model is a large-scale AI system, typically a neural network, trained on broad, vast, and diverse datasets in a self-supervised manner. The term ‘foundation’ implies that these models serve as a base or ‘foundation’ upon which a myriad of more specialized applications can be built with minimal additional training. This foundational capability arises from their ability to learn highly versatile and generalizable representations of data during their initial pre-training phase.

Key characteristics that define foundation models include:

• Scalability: This refers not only to their ability to process and learn from extraordinarily large datasets (often comprising billions or trillions of data points) but also to their inherent design, which allows for continued performance improvements as model size (parameters) and data volume increase. In healthcare, this means handling the ever-growing volumes of EHR data, imaging archives, and genomic sequences without being overwhelmed. The sheer scale allows them to capture subtle patterns and correlations that smaller, task-specific models might miss.

• Adaptability (Transfer Learning): Perhaps the most compelling feature, adaptability refers to the model’s capacity to be efficiently fine-tuned or prompted for a wide array of downstream tasks, even those not explicitly seen during pre-training. This is achieved through transfer learning, where the generalized knowledge acquired during pre-training (e.g., understanding language structures, visual features, or biological sequences) is transferred to new, often data-scarce, tasks. In healthcare, this means a single foundation model pre-trained on diverse medical data could be adapted to diagnose different diseases, predict various patient outcomes, or assist in distinct clinical workflows, dramatically reducing the development time and data annotation burden for new applications. This adaptability also manifests as ‘few-shot’ or ‘zero-shot’ learning, where the model can perform new tasks with very few or no labeled examples, respectively, by leveraging its broad contextual understanding.

• Multimodal Processing: Healthcare data is inherently multimodal, comprising structured numerical data (lab results, vital signs), unstructured text (clinical notes, pathology reports), images (radiology, pathology slides, dermatoscopy), signals (ECG, EEG), and sequences (genomic, proteomic). Foundation models are specifically designed to integrate and analyze these disparate data types concurrently. By learning cross-modal correlations, they can build a more comprehensive and nuanced understanding of a patient’s condition, mirroring the holistic approach of human clinicians. For instance, an AI model could correlate a finding in a radiology image with terms in a clinical note and relevant genomic markers to arrive at a more precise diagnosis.

• Emergent Capabilities: As models scale in size and are trained on increasingly diverse data, they often exhibit ’emergent capabilities’—abilities that were not explicitly programmed or obvious at smaller scales. These can include complex reasoning, improved logical inference, and the ability to synthesize information across various domains. In healthcare, this could manifest as the model demonstrating an unexpected proficiency in differential diagnosis, identifying complex drug-drug interactions, or even proposing novel research hypotheses based on patterns across vast datasets, which are challenging for human experts to discern.

2.2 Architectural Components

The construction of foundation models relies on several sophisticated architectural and algorithmic components that enable their distinctive capabilities:

• Transformer Networks: At the core of most modern foundation models, particularly those excelling in natural language processing (NLP) and increasingly in computer vision and multimodal tasks, are Transformer Networks. Introduced in 2017 by Vaswani et al. in their seminal paper ‘Attention Is All You Need’ (Vaswani et al., 2017), Transformers revolutionized sequence modeling by abandoning recurrent neural networks (RNNs) and convolutional neural networks (CNNs) in favor of a mechanism called self-attention. Self-attention allows the model to weigh the importance of different parts of the input sequence when processing a specific element, capturing long-range dependencies efficiently, which was a significant limitation for earlier architectures. This parallelizable nature of attention mechanisms makes Transformers highly scalable, enabling training on massive datasets across numerous GPUs. In healthcare, Transformers are adept at processing long clinical notes, understanding complex sequential EHR entries, and even encoding medical image patches as sequences, making them versatile for multimodal data integration. The typical architecture involves an encoder-decoder structure or variations thereof, with multiple layers of multi-head self-attention and feed-forward networks. The remarkable scalability of Transformers, often described by ‘scaling laws,’ indicates that performance reliably improves with increased model size, data quantity, and computational budget, a crucial factor for building truly foundational AI.

• Self-Supervised Learning (SSL): A cornerstone of foundation model training, Self-Supervised Learning is a paradigm where the model learns meaningful representations from unlabeled data by generating its own supervisory signals. Instead of relying on costly and time-consuming human annotations, SSL tasks involve predicting missing parts of data, reconstructing corrupted inputs, or finding relationships within the data itself. Common SSL techniques include:

  • Masked Language Modeling (MLM): As seen in BERT (Devlin et al., 2019), parts of the input text are masked, and the model predicts the missing words. In healthcare, this could involve masking medical terms in clinical notes and predicting them, forcing the model to learn medical terminology, contextual understanding, and syntactic structures.
  • Contrastive Learning: Used extensively in computer vision (e.g., SimCLR, MoCo) and increasingly in multimodal settings. The model learns to distinguish between similar (positive pairs) and dissimilar (negative pairs) representations of data. For medical images, this could involve creating different augmentations of the same image (positive pair) and learning to embed them closely, while pushing apart embeddings of different images (negative pairs).
  • Generative Pre-training: Models like GPT (Radford et al., 2018) learn to predict the next token in a sequence. This autoregressive approach enables them to generate coherent and contextually relevant text. In healthcare, this could involve generating synthetic patient records or clinical summaries, or completing partially filled EHRs.
    SSL is particularly valuable in healthcare where high-quality, comprehensively labeled datasets are scarce and expensive to acquire due to privacy concerns, expertise requirements, and time constraints. By leveraging vast amounts of readily available unlabeled medical data, SSL enables foundation models to learn robust and transferable features, significantly reducing the downstream dependency on large annotated datasets for specific tasks.

• Multimodal Integration Architectures: The ability to process and fuse information from different modalities is critical for healthcare applications. Various strategies exist for multimodal integration within foundation models:

  • Early Fusion: Data from different modalities are combined at an early stage, often concatenated or projected into a common embedding space before being fed into the main model architecture (e.g., a Transformer). This allows the model to learn interactions between modalities from the ground up.
  • Late Fusion: Each modality is processed independently by its own sub-model, and their outputs (e.g., predictions or higher-level features) are combined at a later stage, often for a final decision. This approach is simpler but might miss subtle cross-modal interactions.
  • Hybrid Fusion: Combines elements of early and late fusion. For instance, cross-attention mechanisms within a Transformer can allow tokens from one modality (e.g., text) to ‘attend’ to tokens from another modality (e.g., image patches), learning shared representations and inter-modal dependencies.
    In a clinical context, a multimodal foundation model might simultaneously process a patient’s CT scan, their historical clinical notes, their genetic sequence, and their lab results. It would learn to associate visual features from the scan with descriptive text in the notes, genetic predispositions from the genome, and specific biomarkers from lab results to form a comprehensive understanding of the patient’s state, leading to more accurate diagnoses and personalized treatment recommendations.

These architectural components, when combined and scaled appropriately, enable foundation models to learn incredibly rich and generalizable representations of the world, making them exceptionally well-suited for the complex, data-rich, and intrinsically multimodal domain of healthcare.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

3. Advantages of Foundation Models in Healthcare

Foundation models bring a paradigm shift to healthcare AI, offering distinct advantages over traditional, task-specific models. Their generalizability, efficiency, and deep understanding of diverse data types pave the way for numerous improvements across the clinical continuum.

3.1 Enhanced Diagnostic Accuracy and Speed

One of the most immediate and profound benefits of foundation models in healthcare is their capability to process, integrate, and analyze vast and diverse medical data streams, leading to significantly improved diagnostic precision and reduced diagnostic delays. Traditional diagnostic pathways often rely on sequential analysis of information by different specialists, which can be time-consuming and prone to human cognitive biases or limitations in data synthesis.

Foundation models, trained on millions of medical images, extensive EHR entries, and genomic sequences, develop an intricate understanding of disease presentation across various modalities. For instance, a model can correlate subtle patterns in a chest X-ray with specific symptoms described in a patient’s clinical notes and relevant risk factors from their medical history, leading to a more comprehensive and accurate assessment. This multimodal synthesis is critical for complex cases or rare diseases where isolated data points might be inconclusive.

Aidoc’s CARE™ model exemplifies this capability, having been integrated into numerous clinical workflows globally. Its deployment has demonstrably improved the detection and triage of critical conditions across various medical imaging modalities, including pulmonary embolism, intracranial hemorrhage, and aortic dissection. By automatically identifying emergent findings and flagging them for immediate radiologist review, CARE™ has been associated with:

• Reduced Diagnostic Delays: Rapid identification of critical pathologies, often within minutes of image acquisition, allows for faster clinical intervention. This is particularly crucial for time-sensitive conditions like stroke or sepsis, where every minute saved can dramatically impact patient outcomes and survival rates.
• Optimized Patient Outcomes: Early and accurate diagnosis leads to timely initiation of appropriate treatment, preventing disease progression and reducing morbidity and mortality. For example, prompt detection of a large vessel occlusion in stroke patients enables quicker endovascular thrombectomy, minimizing brain damage.
• Improved Consistency: AI models do not suffer from fatigue, distraction, or variations in experience level that can affect human performance. They provide consistent diagnostic support, ensuring a high standard of care even in high-volume settings or during off-hours.
• Aid in Differential Diagnosis: Beyond identifying specific conditions, foundation models can suggest a ranked list of potential diagnoses by evaluating patterns across vast datasets, assisting clinicians in navigating complex clinical presentations and considering less common possibilities.

3.2 Accelerated Development and Deployment of Clinical Applications

The versatility and pre-trained knowledge base of foundation models dramatically accelerate the development and deployment of new clinical AI applications. This is a game-changer for healthcare organizations and AI developers alike, who previously faced significant hurdles in data collection, annotation, and model training for each specific application.

By leveraging pre-trained foundation models, developers can circumvent the need to train models from scratch, which is a computationally intensive and data-hungry process. Instead, they can fine-tune these models with relatively smaller, task-specific datasets, a process known as ‘transfer learning’. This reduces:

• Development Time: Months or even years of development can be compressed into weeks or days, allowing healthcare systems to rapidly respond to emerging clinical needs or integrate new research findings into practice.
• Data Requirements: The heavy reliance on massive, meticulously labeled datasets for initial training is mitigated. While some task-specific data is still needed for fine-tuning, the volume required is significantly less, making AI solutions more accessible even for rare diseases or niche clinical problems where large datasets are impractical to acquire.
• Computational Costs: While pre-training a foundation model is expensive, the subsequent fine-tuning and inference costs for individual applications are much lower, making the overall lifecycle more economically viable.

This accelerated pipeline allows healthcare organizations to expedite the creation of diverse AI tools for purposes such as disease detection, risk stratification (e.g., predicting patients at high risk of readmission or adverse events), treatment planning (e.g., optimizing radiation therapy dosages), and operational efficiency (e.g., predicting patient flow or resource utilization). The ability to rapidly prototype, validate, and deploy solutions enhances the agility of healthcare delivery, allowing for quicker adoption of AI-driven innovations into clinical practice.

3.3 Improved Generalization Across Clinical Tasks and Patient Populations

Traditional AI models often struggle with generalization; a model trained for one type of pneumonia on a specific demographic might perform poorly on a different type of pneumonia or in a different ethnic group or hospital setting. Foundation models, by virtue of their vast and diverse pre-training, exhibit significantly superior generalization capabilities across multiple clinical tasks, patient populations, and even different medical institutions or equipment variations.

Their ability to learn robust, low-level and high-level representations from a broad spectrum of medical data means they are less prone to ‘overfitting’ to specific training data nuances. This leads to:

• Reduced Need for Task-Specific Models: Instead of developing and maintaining dozens or hundreds of individual AI models for each specific clinical problem, a single foundation model can serve as the backbone for numerous applications, simplifying development, deployment, and maintenance efforts. This streamlines the AI portfolio of healthcare systems, ensuring consistency and reliability across AI-driven solutions.
• Robustness to Data Variability: Foundation models are inherently more robust to variations in data quality, imaging protocols, or EHR systems encountered in real-world clinical environments. Their training on diverse datasets from multiple sources allows them to better handle unseen data and variations that would typically cause traditional models to falter.
• Performance on Rare Conditions: For rare diseases, where labeled data is scarce, foundation models can leverage their broad medical understanding to identify subtle patterns or make informed inferences that task-specific models, lacking sufficient examples, would miss. This is crucial for early diagnosis of challenging conditions.

3.4 Enabling Personalized Medicine and Predictive Analytics

Beyond diagnosis and efficiency, foundation models are poised to revolutionize personalized medicine and predictive analytics, shifting healthcare from a reactive to a proactive model. By integrating and analyzing disparate data sources – including clinical notes, lab results, imaging, genomics, wearables data, and even social determinants of health – foundation models can construct highly granular and comprehensive patient profiles.

This holistic view enables:

• Tailored Treatment Plans: Based on a patient’s unique genomic makeup, disease markers, and historical responses to treatments, foundation models can recommend highly personalized therapeutic strategies, optimizing drug dosages, predicting adverse drug reactions, and identifying optimal treatment pathways for complex conditions like cancer or autoimmune diseases. This moves beyond ‘one-size-fits-all’ medicine to precision interventions.
• Proactive Risk Stratification: Models can continuously monitor patient data to identify individuals at high risk for future adverse events, such as cardiac events, sepsis, diabetic complications, or hospital readmissions. This allows clinicians to intervene proactively with preventative measures or intensified monitoring, thereby improving outcomes and reducing healthcare costs.
• Drug Discovery and Repurposing: By analyzing vast biomedical literature, clinical trial data, and molecular datasets, foundation models can accelerate the identification of novel drug targets, predict the efficacy and safety of new compounds, and even suggest existing drugs that could be repurposed for new indications, significantly shortening the drug development pipeline.

These advantages collectively underscore the transformative potential of foundation models, positioning them not merely as tools for automation but as intelligent assistants capable of augmenting human expertise, accelerating medical discovery, and paving the way for a new era of highly efficient, accurate, and personalized healthcare.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

4. Integration with Electronic Health Records (EHRs)

Electronic Health Records (EHRs) serve as the backbone of modern healthcare, compiling an immense wealth of patient information. From detailed medical histories and demographic data to lab results, medication lists, physician’s notes, and treatment plans, EHRs are repositories of a patient’s entire clinical journey. Leveraging this data effectively is paramount for advancing patient care, clinical research, and operational efficiency.

4.1 Challenges in EHR Data Processing

Despite their undeniable value, extracting actionable insights from EHRs presents a myriad of formidable challenges for conventional computational approaches, primarily due to the inherent complexity and heterogeneity of the data:

• Data Heterogeneity and Unstructured Nature: A significant portion of EHR data is unstructured text, found in clinical notes, discharge summaries, pathology reports, and radiology interpretations. This free-text format contains invaluable context and nuance that structured fields often lack. However, extracting this information requires advanced Natural Language Processing (NLP) techniques. Moreover, even structured data can be heterogeneous, employing various coding systems (e.g., ICD-10 for diagnoses, CPT for procedures, SNOMED CT for clinical terms, LOINC for lab tests) that require careful mapping and standardization.
• Temporal Sparsity and Irregularity: Patient data in EHRs is often recorded irregularly, based on clinical encounters or specific tests. This leads to temporal sparsity, where long gaps can exist between data points, making it challenging to capture continuous physiological changes or disease trajectories accurately. Events might not be timestamped precisely or recorded consistently.
• Missing and Incomplete Data: Due to various reasons such as human error, interoperability issues, patient non-compliance, or a lack of documentation standards, EHRs frequently contain missing data points. This can range from absent lab results to incomplete symptom descriptions, posing significant challenges for model training and inference.
• Data Quality Issues: EHRs can suffer from typographical errors, inconsistencies, outdated information, and even conflicting entries. These data quality issues can propagate through analytical pipelines, leading to erroneous conclusions.
• Privacy and Security Concerns (HIPAA, GDPR): EHRs contain highly sensitive Protected Health Information (PHI). Strict regulations such as HIPAA in the United States and GDPR in Europe impose rigorous requirements for data privacy, security, and access control. De-identification, pseudonymization, and secure data sharing protocols are essential, yet challenging, to implement and enforce, limiting the ease of data aggregation for large-scale model training.
• Context Length Limitations: Many traditional NLP models, particularly early Transformers, had limitations on the maximum sequence length they could process. Clinical notes, patient histories, and longitudinal EHRs can be extremely long, often exceeding these limits, necessitating chunking or truncation that can lead to loss of critical context.

4.2 Role of Foundation Models in EHR Analysis

Foundation models, with their advanced architectural components and self-supervised learning capabilities, are uniquely positioned to address many of these challenges, transforming EHR analysis into a powerful engine for clinical insights:

• Data Standardization and Normalization: Foundation models, through their deep understanding of semantic relationships learned from vast textual corpora, can learn to map disparate coding systems and normalize clinical concepts embedded in free text. They can effectively bridge the gaps between ICD codes, SNOMED terms, and clinical narrative, creating a more unified and consistent representation of patient data.
• Information Extraction and Semantic Understanding: Leveraging their powerful NLP capabilities, foundation models can accurately extract structured information (e.g., diagnoses, medications, dosages, procedures, adverse events) from unstructured clinical notes. More importantly, they can infer the semantic meaning and relationships between these extracted entities, allowing for sophisticated queries and contextual understanding that goes beyond simple keyword matching. For example, distinguishing between ‘patient has fever’ and ‘patient denies fever’.
• Predictive Analytics: By integrating temporal sequences of structured and unstructured EHR data, foundation models can excel at a wide range of predictive tasks, offering proactive clinical decision support. This includes:
  • Predicting Patient Outcomes: Such as hospital readmission risk, risk of sepsis, stroke, or acute kidney injury.
  • Disease Progression: Forecasting the trajectory of chronic diseases like diabetes, heart failure, or neurological disorders.
  • Treatment Response: Predicting a patient’s likely response to specific medications or interventions, aiding in personalized therapy selection.
  • Adverse Drug Events: Identifying potential drug-drug interactions or adverse reactions before they occur.
  • Risk Stratification: Grouping patients based on their risk profiles for targeted interventions.
• Clinical Decision Support (CDS): Foundation models can act as intelligent assistants to healthcare providers, offering real-time insights and recommendations at the point of care. They can summarize lengthy patient histories, highlight critical lab values or drug interactions, suggest relevant diagnostic pathways, and even generate concise patient summaries for handover between shifts, reducing cognitive load and improving decision-making accuracy.
• Population Health Management: By analyzing trends and patterns across aggregated EHR data from large patient cohorts, foundation models can identify population-level health risks, inform public health interventions, optimize resource allocation, and detect outbreaks of infectious diseases earlier.

4.3 Case Study: EHRMamba – A Breakthrough in EHR Foundation Models

The paper ‘EHRMamba: Towards Generalizable and Scalable Foundation Models for Electronic Health Records’ by Fallahpour et al. (2024) presents a compelling case study illustrating the potential of foundation models specifically tailored for EHR data. EHRMamba addresses critical limitations of traditional Transformer-based models when applied to longitudinal EHR sequences, namely their quadratic computational cost with respect to sequence length and their inherent context length limitations.

The Mamba Architecture: EHRMamba leverages the innovative Mamba architecture, which is based on State Space Models (SSMs). Unlike Transformers, Mamba models exhibit linear computational complexity with respect to sequence length, allowing them to process exceptionally long sequences characteristic of comprehensive patient histories without the prohibitive computational burden. This linear scaling is crucial for EHR data, where a patient’s record can span decades and comprise thousands of entries, requiring a vast context window for accurate understanding.

Multitask Prompted Fine-Tuning: A key innovation in EHRMamba’s approach is its use of ‘multitask prompted fine-tuning’. Instead of training separate models for each downstream task, EHRMamba is fine-tuned to perform multiple clinical prediction tasks simultaneously by using distinct textual prompts. For example, a prompt like ‘Predict the patient’s diagnosis’ would elicit a diagnostic prediction, while ‘Predict the length of hospital stay’ would elicit a different output from the same underlying model. This strategy further enhances the model’s generalization capabilities and efficiency, as it learns shared representations beneficial across various clinical objectives.

Performance and Advantages: EHRMamba demonstrated improved performance across a diverse suite of clinical tasks, including diagnosis prediction, phenotyping, and length-of-stay prediction. Its ability to handle long patient histories without memory bottlenecks or performance degradation due to truncation represents a significant advantage over traditional Transformer models. This case study highlights how specialized architectures, combined with efficient fine-tuning strategies, can overcome the unique challenges of EHR data, bringing the benefits of foundation models closer to widespread clinical adoption. The success of EHRMamba underscores the potential for foundation models to become universal encoders and predictors for patient journey analysis, laying the groundwork for more comprehensive and proactive patient management systems.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

5. Integration with Medical Imaging

Medical imaging plays an indispensable role in modern diagnostics, guiding therapeutic interventions, and monitoring disease progression. Techniques such as X-rays, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound, and Positron Emission Tomography (PET) provide invaluable visual insights into the human body.

5.1 Advancements in Medical Imaging AI

The application of AI in medical imaging has a rich history, evolving significantly over the past decades. Early AI systems focused on rule-based image processing and feature engineering for tasks like organ segmentation or simple anomaly detection. The advent of deep learning, particularly Convolutional Neural Networks (CNNs), revolutionized the field in the early 2010s, enabling automated image analysis with unprecedented accuracy.

Deep learning models have excelled in tasks such as:

• Image Classification: Identifying the presence or absence of disease (e.g., classifying a mammogram as malignant or benign).
• Object Detection: Localizing specific structures or pathologies within an image (e.g., detecting lung nodules in CT scans).
• Image Segmentation: Delineating anatomical structures or lesions with pixel-level precision (e.g., segmenting tumors for radiation therapy planning or brain structures for neurosurgery).
• Image Reconstruction and Enhancement: Improving image quality from raw data, reducing noise, or generating higher-resolution images.

However, even state-of-the-art CNNs often require vast amounts of meticulously labeled data, which in medical imaging means annotations by highly trained radiologists or pathologists. This annotation process is expensive, time-consuming, and subject to inter-observer variability, creating a bottleneck for widespread AI development and generalization across diverse clinical scenarios or imaging modalities.

5.2 Foundation Models in Imaging Analysis

Foundation models address the limitations of traditional imaging AI by leveraging self-supervised learning on massive, unlabeled image datasets, allowing them to learn highly robust and generalizable visual representations. These models can then be adapted to a wide array of medical imaging tasks with significantly less task-specific labeled data.

Key applications and advantages of foundation models in imaging analysis include:

• Enhanced Image Interpretation: Foundation models can provide more accurate and context-aware analyses by understanding not just individual pixels but also the broader anatomical context and subtle disease patterns. They can assist radiologists in:
  • Lesion Detection and Characterization: Automatically identifying and characterizing abnormalities (e.g., detecting subtle intracranial hemorrhages, classifying liver lesions).
  • Quantification: Precisely measuring lesion size, volume, or progression over time, crucial for treatment monitoring.
  • Multi-organ and Systemic Assessment: Understanding how findings in one organ might relate to conditions elsewhere in the body, facilitating a holistic diagnostic approach.
• Automated Report Generation and Clinical Summarization: By integrating visual features with learned language representations, foundation models can automatically generate preliminary radiology reports or structured summaries directly from imaging data. This reduces the time radiologists spend on repetitive reporting tasks, allowing them to focus on complex cases and patient interaction. These reports can be context-aware, highlighting critical findings and their potential implications.
• Multimodal Diagnostics and Data Fusion: Integrating imaging data with other clinical information (e.g., EHRs, lab results, genomic data) is where foundation models truly shine. They can correlate visual findings (e.g., a tumor’s appearance on an MRI) with patient symptoms from notes, specific biomarkers from lab results, and genetic predispositions, leading to a more comprehensive and accurate diagnosis. For instance, a model could integrate a suspicious finding on a CT scan with a patient’s smoking history and genetic markers to assess lung cancer risk more accurately than from the scan alone.
• Early Disease Detection and Screening: Foundation models can be trained on large populations to detect subtle early signs of disease that might be missed by the human eye, improving screening programs for conditions like breast cancer, diabetic retinopathy, or cardiovascular disease.
• Treatment Response Assessment: By comparing sequential images over time, foundation models can accurately assess a patient’s response to therapy (e.g., tumor shrinkage, changes in inflammation), guiding treatment adjustments.

5.3 Case Study: Aidoc’s CARE™ in Imaging – A Clinical-Grade Foundation Model

Aidoc’s CARE™ model represents a pioneering application of foundation model principles to clinical imaging workflows, demonstrating tangible improvements in patient care and operational efficiency. Unlike models focused on single pathologies or modalities, CARE™ is designed to be a comprehensive AI platform that can detect and triage a wide array of critical conditions across various medical imaging modalities, including CT, MRI, and X-ray.

Architecture and Training: While specific architectural details are proprietary, CARE™ is understood to leverage a large-scale architecture pre-trained on an enormous dataset of medical images and associated clinical text from diverse sources. This pre-training enables it to learn universal visual features and relationships that are transferable across different anatomical regions, image acquisition parameters, and clinical indications.

Clinical Integration and Impact: Aidoc’s CARE™ has been integrated into numerous hospital systems globally, acting as an AI orchestration platform that works seamlessly within existing PACS (Picture Archiving and Communication System) and EHR workflows. Its primary function is to:

• Real-time Triage and Prioritization: Immediately after an imaging study is acquired, CARE™ analyzes the images for critical findings. If a time-sensitive condition (e.g., large vessel occlusion stroke, pulmonary embolism, intracranial hemorrhage, aortic dissection) is detected, the system automatically flags the study and sends an urgent notification to the radiologist, often within minutes. This ensures that life-threatening cases are reviewed first, significantly reducing the ‘time-to-read’ and ‘time-to-diagnosis’ for critical conditions.
• Augmenting Radiologist Workflow: Beyond critical findings, CARE™ also assists in routine interpretation, providing automated measurements, segmentations, and highlighting subtle anomalies that might otherwise be overlooked. This augments the radiologist’s capabilities, potentially reducing reporting errors and improving overall diagnostic accuracy.
• FDA Clearances: Aidoc has achieved multiple landmark FDA clearances for its AI solutions powered by the CARE™ foundation model. These clearances signify rigorous validation for safety, efficacy, and clinical utility. For example, the FDA clearance for its detection of acute intracranial hemorrhage and large vessel occlusion demonstrates its capability to directly impact patient management in emergency settings. These clearances are crucial for establishing trust and enabling widespread adoption in regulated clinical environments.
• Quantifiable Outcomes: Studies and real-world deployments of Aidoc’s CARE™ have consistently shown association with:
  • Reduced Diagnostic Delays: As highlighted earlier, speeding up diagnosis for conditions where minutes matter.
  • Improved Patient Outcomes: By enabling earlier treatment initiation.
  • Optimized Radiologist Workflow: Reducing burnout by prioritizing urgent cases and automating mundane tasks, allowing radiologists to focus their expertise on complex interpretations.

The success of Aidoc’s CARE™ underscores the practical utility and transformative potential of clinical-grade foundation models in medical imaging. By moving beyond single-task automation to providing a comprehensive, adaptable AI backbone for imaging diagnostics, these models are fundamentally reshaping radiology practice and contributing to higher standards of patient care.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

6. Integration with Genomic Data

Genomic data, encompassing an individual’s complete set of DNA, provides an unparalleled blueprint of their biological make-up. The ability to sequence and interpret this vast information has propelled healthcare into the era of personalized medicine, offering profound insights into disease predisposition, underlying mechanisms, and highly individualized treatment responses.

6.1 Importance of Genomic Data in Healthcare

The integration of genomic information into clinical practice holds immense promise across several critical areas:

• Personalized Medicine (Precision Medicine): Tailoring medical treatment to the individual characteristics of each patient. Genomic data allows for the selection of therapies most likely to be effective and safe, minimizing trial-and-error approaches. This is particularly transformative in oncology (pharmacogenomics for cancer drugs), rare diseases, and chronic conditions.
• Pharmacogenomics: Understanding how an individual’s genetic variations influence their response to drugs. This can predict drug efficacy, adverse drug reactions, and guide optimal dosing, leading to safer and more effective prescriptions.
• Risk Assessment and Prevention: Identifying genetic predispositions to common complex diseases (e.g., heart disease, diabetes, certain cancers) or rare Mendelian disorders. This allows for proactive screening, lifestyle modifications, or preventative interventions for at-risk individuals.
• Diagnosis of Rare and Undiagnosed Diseases: For patients with complex, atypical symptoms, whole-exome or whole-genome sequencing can identify causative genetic variants, often leading to a diagnosis after years of uncertainty.
• Oncology: Genomic profiling of tumors is now standard practice for many cancers, identifying actionable mutations that guide targeted therapies and immunotherapies, influencing prognosis and treatment strategies.
• Reproductive Health: Genetic screening for carriers of inherited disorders, prenatal diagnosis, and preimplantation genetic diagnosis.
• Understanding Disease Mechanisms: Genomic studies contribute fundamentally to unraveling the molecular basis of diseases, paving the way for novel therapeutic targets and drug development.

Types of genomic data include Whole-Genome Sequencing (WGS), Whole-Exome Sequencing (WES), RNA sequencing (RNA-seq) for gene expression, single-cell genomics, epigenomics, and array-based genotyping.

6.2 Challenges in Genomic Data Analysis

While genomic data offers incredible potential, its analysis and interpretation present unique and formidable challenges:

• High Dimensionality and Volume: A single human genome sequence comprises approximately 3 billion base pairs. Analyzing this immense volume of data, identifying meaningful variations (single nucleotide polymorphisms, insertions/deletions, structural variants), and distinguishing pathogenic variants from benign polymorphisms is computationally intensive. The ‘signal-to-noise’ ratio can be very low, as only a small fraction of variants are clinically relevant.
• Interpretation Complexity: Linking specific genetic variants to complex phenotypic traits or disease states is profoundly challenging due to pleiotropy (one gene affecting multiple traits), epistasis (gene-gene interactions), gene-environment interactions, and incomplete penetrance (individuals with the genetic variant not developing the associated condition). Understanding the functional consequences of non-coding variants is particularly difficult.
• Data Storage and Management: Storing and managing petabytes of raw and processed genomic data, especially across large cohorts, requires significant computational infrastructure and robust data management strategies.
• Ethical, Legal, and Social Implications (ELSI): Genomic data is inherently identifiable and carries significant implications for privacy, discrimination (e.g., in insurance or employment), and informed consent. There are ethical dilemmas around incidental findings (discovering an unrelated disease risk), sharing data, and ensuring equitable access to genomic technologies.
• Lack of Comprehensive Knowledge Bases: While databases like ClinVar and gnomAD exist, the functional impact and clinical significance of many genetic variants remain unknown or are inconsistently annotated. The pace of discovery outstrips the ability to curate knowledge.
• Population Specificity: Genetic variations and their disease associations can differ significantly across diverse ethnic and ancestral populations. Lack of genomic diversity in existing datasets can lead to algorithmic bias and reduced clinical utility for underrepresented groups.

6.3 Role of Foundation Models in Genomic Analysis

Foundation models, with their capacity to learn complex patterns from massive, high-dimensional datasets and integrate disparate information, are exceptionally well-suited to address the complexities of genomic data analysis:

• Variant Prioritization and Interpretation: Foundation models, trained on vast genomic sequences, protein structures, and associated clinical phenotypes, can predict the pathogenicity of novel or rare genetic variants more accurately. They can learn the functional consequences of mutations (e.g., how a single nucleotide change affects protein folding, gene expression, or splicing) and prioritize variants most likely to be causative for a patient’s symptoms.
• Disease Risk Prediction and Polygenic Risk Scores (PRS): Beyond single-gene disorders, foundation models can integrate millions of common genetic variants with clinical and lifestyle factors to generate more accurate Polygenic Risk Scores (PRS) for complex diseases like heart disease, diabetes, or Alzheimer’s. They can learn subtle additive and interactive effects across the genome.
• Pharmacogenomics and Drug Response Prediction: By analyzing a patient’s genetic profile in conjunction with drug mechanism-of-action data and clinical trial outcomes, foundation models can predict individual responses to specific medications, optimizing drug selection and dosing to maximize efficacy and minimize adverse effects.
• Drug Discovery and Target Identification: Foundation models can accelerate drug discovery by identifying novel therapeutic targets from genomic and proteomic data, predicting the efficacy and safety of new drug compounds, and even designing optimized molecules. They can sift through vast chemical and biological spaces to pinpoint promising candidates.
• Genomic-Phenomic Correlation: By integrating genomic data with comprehensive phenotypic information from EHRs (clinical notes, lab results, imaging), foundation models can uncover novel associations between genetic markers and clinical manifestations. This helps in understanding disease etiology, identifying new biomarkers, and refining disease classifications.
• Population-Specific Insights: With access to diverse genomic datasets (federated learning can help here), foundation models can learn population-specific genetic architectures, leading to more equitable and accurate risk predictions and treatment recommendations across different ancestries.
• Epigenomic and Gene Regulation Insights: Beyond DNA sequence, foundation models can also analyze epigenetic modifications (e.g., DNA methylation, histone modifications) and their impact on gene expression and disease, adding another layer of biological understanding.

Specialized architectures, such as genomic Transformers (e.g., for DNA sequence analysis similar to large language models) and Graph Neural Networks (GNNs) (for analyzing complex biological networks involving genes, proteins, and metabolites), are being developed or adapted within the foundation model paradigm to handle the unique structure and relationships within genomic data. These models promise to unlock the full potential of genomic medicine, moving beyond mere data storage to comprehensive, actionable genomic insights that drive truly personalized and preventive healthcare.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

7. Challenges in Deploying Foundation Models in Clinical Settings

The immense potential of foundation models in healthcare is balanced by a set of significant, multifaceted challenges that must be meticulously addressed to ensure their safe, ethical, and effective deployment in real-world clinical environments.

7.1 Data Governance, Privacy, and Security

Healthcare data, particularly patient health information (PHI), is among the most sensitive types of data, making stringent data governance, privacy, and security paramount. Foundation models, by their very nature, require access to vast datasets, exacerbating these concerns:

• Regulatory Compliance: Adhering to strict regulations like the Health Insurance Portability and Accountability Act (HIPAA) in the United States, the General Data Protection Regulation (GDPR) in Europe, and numerous other national and regional laws (e.g., CCPA, LGPD) is non-negotiable. These regulations govern how PHI is collected, stored, processed, shared, and accessed. Non-compliance can lead to severe legal penalties, reputational damage, and erosion of public trust.
• Privacy-Preserving Technologies: Training foundation models often involves pooling data from multiple institutions, raising concerns about data re-identification risks. Technologies like federated learning (discussed in Section 8.1), homomorphic encryption, and secure multi-party computation (SMPC) are crucial for allowing models to learn from decentralized datasets without directly exposing raw patient data. Differential privacy techniques can also be applied during model training to mathematically guarantee a certain level of privacy, even if the model is later queried.
• Data De-identification and Anonymization: While de-identification aims to remove identifiable information, the sheer volume and granularity of data often used by foundation models raise concerns about the possibility of re-identification, especially when combined with external datasets. Synthetic data generation, which creates artificial datasets with similar statistical properties but no direct link to real individuals, offers a promising avenue but faces challenges in maintaining clinical realism.
• Data Silos and Interoperability: Healthcare data is often fragmented across different systems within a single institution (e.g., separate EHR, PACS, lab systems) and even more so across different healthcare providers. Lack of standardized data formats and robust interoperability standards makes it challenging to aggregate the diverse and multimodal data required for training truly comprehensive foundation models.
• Data Provenance and Bias Management: Ensuring that the training data is representative, accurate, and free from biases (e.g., historical underrepresentation of certain demographic groups) is critical. Robust data governance frameworks must track data provenance and implement strategies for bias detection and mitigation from the earliest stages of data collection.

7.2 Computational Resources and Infrastructure

Training and deploying large-scale foundation models demand substantial computational power, presenting a significant barrier for many healthcare institutions:

• High Performance Computing (HPC) Infrastructure: Training a foundation model with billions of parameters can require thousands of Graphics Processing Units (GPUs) or specialized AI accelerators, running for weeks or months. This necessitates massive data centers, robust cooling systems, and reliable power supply, representing a capital expenditure that few individual hospitals can afford.
• Energy Consumption and Environmental Impact: The energy required for training and operating these models is substantial, contributing to a significant carbon footprint. Sustainable AI development practices and energy-efficient hardware become increasingly important considerations.
• Cost of Cloud Computing: While cloud platforms (AWS, Azure, GCP) offer scalability, the operational costs for large-scale training and continuous inference can be prohibitive for long-term clinical deployment. Hospitals need to weigh the benefits against the ongoing operational expenses.
• IT Expertise and Management: Deploying and maintaining complex AI models requires specialized IT expertise in machine learning operations (MLOps), cybersecurity, data engineering, and system integration, which are often scarce resources in healthcare settings.
• Inference Costs and Latency: Even after training, running large models for real-time clinical inference can demand significant computational resources, impacting operational costs and potentially introducing latency that is unacceptable for time-critical applications like surgical guidance or emergency diagnostics.

7.3 Model Interpretability, Explainability, and Trust (XAI)

For AI models to be adopted in clinical practice, healthcare providers must understand why a model makes a particular recommendation or prediction and be able to trust its output. This is the realm of Explainable AI (XAI):

• Black-Box Problem: Many foundation models, due to their intricate neural network architectures and immense complexity, operate as ‘black boxes.’ It is challenging to trace the specific data points or internal logic that led to a particular output, making it difficult for clinicians to scrutinize or validate the model’s reasoning.
• Clinical Acceptance and Trust: Clinicians are ultimately responsible for patient care. They cannot blindly accept AI recommendations without a clear understanding of the underlying rationale, especially in high-stakes situations. Lack of interpretability can lead to low adoption rates and mistrust, hindering the clinical utility of even highly accurate models.
• Legal and Ethical Accountability: In cases of AI-related diagnostic errors or adverse events, the ability to explain the model’s decision-making process is crucial for legal accountability, liability assignment, and regulatory compliance.
• Methods for XAI: While techniques like LIME (Local Interpretable Model-agnostic Explanations), SHAP (SHapley Additive exPlanations), and attention map visualizations exist, their effectiveness for extremely large, multimodal foundation models is still an active area of research. Developing intrinsically interpretable architectures and methods that provide clinically meaningful explanations remains a significant challenge.

7.4 Ethical Considerations and Bias

Addressing biases in AI models is critically important to prevent exacerbating existing disparities in healthcare delivery and to ensure equitable care for all patient populations:

• Sources of Bias: Foundation models learn from the data they are trained on, and if this data reflects historical biases, the models will perpetuate or even amplify them. Sources of bias include:
  • Selection Bias: Training data not representing the full diversity of patient populations (e.g., overrepresentation of Caucasian males in medical datasets).
  • Annotation Bias: Human annotators introducing their own biases into labeled data.
  • Outcome Bias: Historical clinical decisions, which may reflect systemic biases, are embedded in the EHR data.
  • Algorithmic Bias: Bias introduced in the model’s architecture or training process itself.
• Impact of Bias: Biased AI models can lead to misdiagnosis, delayed treatment, or inappropriate care for marginalized groups (e.g., women, racial and ethnic minorities, individuals from lower socioeconomic backgrounds). For instance, a skin cancer detection model trained primarily on light skin tones might perform poorly on darker skin types.
• Fairness and Equity: Ensuring that foundation models perform equally well across different demographic subgroups and do not lead to disparate impacts on vulnerable populations is a fundamental ethical imperative. This requires rigorous evaluation for fairness metrics (e.g., equal accuracy, equal opportunity, demographic parity) and proactive strategies for bias mitigation.
• Accountability and Oversight: Establishing clear lines of accountability for the development, deployment, and monitoring of AI models in healthcare is essential. This includes creating interdisciplinary ethical review boards and establishing mechanisms for continuous post-market surveillance to detect and address emerging biases.

7.5 Regulatory Approval and Clinical Validation

Bringing AI-powered medical devices to market is a rigorous process, requiring extensive regulatory approval and robust clinical validation:

• FDA and Other Regulatory Bodies: In the US, AI tools intended for clinical use are considered Software as a Medical Device (SaMD) by the FDA and require pre-market authorization. This involves demonstrating safety and effectiveness through clinical trials, often requiring comparison against predicate devices or a De Novo pathway for novel technologies. Regulatory frameworks in Europe (MDR), UK (MHRA), and other regions also impose strict requirements.
• Clinical Trial Design: Designing clinical trials for AI models presents unique challenges, including choosing appropriate endpoints, blinding strategies, and ensuring sufficient statistical power to demonstrate clinical utility and superiority over existing methods.
• Generalizability Across Settings: Regulatory bodies increasingly demand evidence that AI models perform robustly across diverse clinical settings, patient populations, and hardware configurations—a challenge for models that may overfit to their training environment.
• Version Control and Continuous Learning: As foundation models are designed for continuous learning and adaptation, managing model updates and re-approvals with regulatory bodies becomes a complex logistical and regulatory challenge, often requiring a ‘change management’ framework that is still evolving.
• Post-Market Surveillance: Continuous monitoring of AI model performance in real-world clinical use is critical for detecting drift, bias, or unforeseen issues, ensuring ongoing safety and effectiveness. This requires robust feedback loops between clinical users and AI developers.

Addressing these comprehensive challenges requires a multi-stakeholder approach involving AI developers, healthcare providers, policymakers, regulatory bodies, and patients themselves. Only through collaborative and proactive efforts can the full potential of foundation models in transforming healthcare be responsibly and equitably realized.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

8. Future Directions

As foundation models continue to evolve, several key areas will shape their future trajectory and successful integration into healthcare, focusing on enhancing privacy, ensuring adaptability, fostering collaboration, and embracing advanced AI paradigms.

8.1 Federated Learning and Enhanced Data Privacy

One of the most promising avenues for overcoming data privacy concerns and data silos in healthcare is federated learning (FL). FL is a decentralized machine learning paradigm that enables the collaborative training of a shared global model across multiple data owners (e.g., hospitals, clinics, research institutions) without requiring them to centralize or directly share their raw sensitive data (Li et al., 2024).

How Federated Learning Works: Instead of data moving to the model, the model (or its parameters/updates) moves to the data. Each participating institution trains a local model on its own private dataset. Periodically, these local models’ weight updates or gradients are encrypted and sent to a central server, which then aggregates these updates to refine a global model. This global model’s updated parameters are then sent back to the local institutions for further training cycles. Crucially, the raw patient data never leaves the local institution’s secure environment.

Benefits for Healthcare:

• Enhanced Data Privacy and Security: Directly addresses concerns about sharing sensitive PHI, complying with regulations like HIPAA and GDPR, and mitigating re-identification risks. This is especially vital for large-scale foundation model training that requires vast, diverse datasets.
• Overcoming Data Silos: Facilitates collaboration among multiple healthcare organizations, allowing them to leverage collective data diversity (e.g., different patient populations, diseases, imaging protocols) to train more robust and generalizable foundation models without compromising data ownership or privacy.
• Access to Underserved Populations: Enables the inclusion of data from smaller clinics or institutions serving specific populations, leading to more representative training data and reducing algorithmic bias against underrepresented groups.
• Reduced Communication Overhead: Only model updates, not raw data, are transmitted, which can be more efficient than moving massive datasets.

Challenges in Federated Learning for Foundation Models:

• Data Heterogeneity (Non-IID Data): Data across different institutions often follows different distributions (non-IID), which can challenge model convergence and performance. Strategies like personalized federated learning are emerging to address this.
• Communication Overhead: While less than raw data transfer, frequent exchange of model updates can still be substantial for very large foundation models, requiring robust network infrastructure.
• Security and Robustness: FL is not entirely immune to attacks; malicious participants could try to infer private data from model updates or poison the global model. Robust cryptographic techniques and differential privacy guarantees are necessary.
• Incentivization and Governance: Establishing clear agreements and incentives for institutions to participate and contribute high-quality data to a shared FL initiative is crucial for widespread adoption.

8.2 Continuous Learning, Adaptation, and Model Evolution

Medical knowledge is not static; it constantly evolves with new research, clinical trials, and emerging disease patterns. For foundation models to remain clinically relevant and effective, they must be capable of continuous learning and adaptation rather than being static entities. This involves:

• Lifelong Learning/Online Learning: Models should be able to incrementally learn from new data as it becomes available without forgetting previously acquired knowledge (catastrophic forgetting). This allows them to adapt to new clinical guidelines, newly identified disease variants, or changes in treatment protocols in real-time or near real-time.
• Domain Adaptation: As models are deployed in new hospitals or regions with slightly different patient demographics, equipment, or clinical practices, they need to quickly adapt their learned representations to the new domain without extensive re-training. This is particularly relevant for ensuring generalization and avoiding performance degradation in real-world heterogeneous environments.
• Managing Model Drift: Clinical phenomena can change over time (e.g., antibiotic resistance patterns, prevalence of certain conditions, shifts in imaging technology). Foundation models must have mechanisms to detect ‘model drift’ (when model performance degrades due to changes in data distribution) and automatically retrain or fine-tune themselves to maintain accuracy and reliability.
• Feedback Loops: Implementing robust feedback mechanisms from clinicians and patient outcomes is essential. This allows the model to learn from its mistakes, reinforce correct predictions, and refine its understanding based on real-world clinical validation.

This continuous evolution paradigm ensures that foundation models remain at the forefront of medical knowledge, providing up-to-date and highly relevant clinical insights throughout their operational lifecycle.

8.3 Collaboration Between AI Developers, Healthcare Providers, and Policy Makers

The successful integration of foundation models into healthcare is not merely a technological challenge but fundamentally a collaborative endeavor. It requires seamless interaction and co-creation among diverse stakeholders:

• AI Developers (Researchers, Engineers): Responsible for building, training, and optimizing the models. They need to understand the nuances of clinical workflows, data types, and the specific needs and pain points of healthcare professionals.
• Healthcare Providers (Clinicians, Administrators, IT Staff): Crucial for providing real-world clinical expertise, validating AI outputs, identifying unmet needs, and ensuring that AI solutions integrate smoothly into existing workflows. Their feedback is invaluable for iterative design and refinement.
• Policy Makers and Regulatory Bodies: Essential for establishing clear, adaptive regulatory frameworks, ethical guidelines, and reimbursement policies that foster innovation while ensuring patient safety, data privacy, and equitable access. They must navigate the complexities of AI liability, intellectual property, and standards for validation.
• Patients and Patient Advocates: Their perspectives are vital in ensuring that AI solutions are patient-centric, address genuine needs, respect patient autonomy, and build trust in AI-driven healthcare.

Key Aspects of Collaboration:

• Iterative Design and User-Centered Development: AI solutions should be co-designed with clinicians from the outset, ensuring practicality, usability, and clinical utility. This often involves prototyping, testing in simulated environments, and pilot deployments.
• Interdisciplinary Teams: Forming teams that combine expertise in AI, medicine, ethics, law, and healthcare operations is essential for addressing the multifaceted challenges of deployment.
• Education and Training: Clinicians and healthcare staff need to be educated on the capabilities, limitations, and responsible use of AI tools. AI developers, in turn, need to immerse themselves in clinical environments to appreciate practical constraints.
• Standardized Benchmarks and Evaluation: Collaborative efforts are needed to establish robust, clinically relevant benchmarks and evaluation frameworks for foundation models, moving beyond purely technical metrics to assess real-world impact on patient outcomes, efficiency, and equity.
• Transparent Communication: Open communication channels between all stakeholders are vital for discussing risks, benefits, and evolving challenges.

8.4 Hybrid AI Systems: Combining Strengths

While foundation models excel at learning complex patterns from vast data, they can sometimes lack inherent interpretability or struggle with domain-specific explicit knowledge. Future directions will increasingly focus on hybrid AI systems that combine the strengths of data-driven foundation models with symbolic AI approaches (e.g., knowledge graphs, expert systems, logical reasoning).

• Knowledge Graphs: Integrating foundation models with curated medical knowledge graphs (e.g., SNOMED CT, Orphanet, DrugBank) can ground the models’ predictions in established medical facts, enhance interpretability, and allow for logical inference based on codified relationships (e.g., drug-disease associations, gene pathways).
• Expert Systems: Augmenting foundation models with rule-based expert systems can provide explicit guardrails, ensure adherence to clinical guidelines, and handle edge cases where statistical patterns might be unreliable.
• Neuro-Symbolic AI: This emerging field aims to seamlessly integrate neural networks with symbolic reasoning. For foundation models in healthcare, this could mean models that not only recognize patterns in images but also reason about anatomical relationships or physiological processes based on explicit medical knowledge.

Hybrid systems promise to offer the best of both worlds: the powerful pattern recognition and generalization of foundation models, combined with the transparency, domain-specific accuracy, and explainability of symbolic AI, leading to more robust and trustworthy clinical AI solutions.

8.5 Trustworthy and Ethical AI Development as a Core Principle

Beyond simply addressing challenges, future development of foundation models in healthcare must embed trust and ethics as core, proactive design principles rather than reactive fixes. This involves:

• AI Explainability (XAI) as a Design Goal: Developing intrinsically interpretable model architectures and ensuring that explanation methods (e.g., saliency maps, feature attribution) provide clinically actionable insights. This involves research into how to distill complex model behaviors into human-understandable terms.
• Fairness by Design: Proactively identifying and mitigating biases throughout the AI lifecycle—from data collection and annotation to model training, evaluation, and deployment. This includes developing robust fairness metrics, auditing models for disparate impacts across subgroups, and implementing techniques like re-weighting, adversarial debiasing, or post-processing to ensure equitable outcomes.
• Robustness and Reliability: Ensuring that models are resilient to adversarial attacks, noisy data, or subtle input perturbations that could lead to erroneous and potentially harmful predictions in a clinical setting. This involves rigorous testing and validation in real-world conditions.
• Human-in-the-Loop Systems: Designing AI systems not to replace but to augment human decision-making. Clinicians should remain in control, having the ability to override AI recommendations, provide feedback, and understand the rationale. The focus should be on building effective human-AI collaboration.
• Value Alignment: Ensuring that AI systems align with core medical ethics principles such as beneficence (doing good), non-maleficence (doing no harm), autonomy (respecting patient choice), and justice (fairness and equity). This requires ongoing dialogue with ethicists, legal experts, and patient communities.

By prioritizing these future directions, the healthcare community can responsibly harness the immense power of foundation models, transforming them into reliable, trustworthy, and equitable tools that genuinely improve patient care and advance medical science.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

9. Conclusion

Foundation models represent a monumental advancement in the application of artificial intelligence within the healthcare landscape, offering a transformative potential to reshape clinical practice, accelerate medical discovery, and profoundly enhance patient care. Their distinguishing characteristics—unprecedented scalability, remarkable adaptability, inherent multimodal processing capabilities, and the emergence of sophisticated reasoning abilities—enable them to transcend the limitations of traditional, task-specific AI models. By learning generalized representations from vast and diverse datasets encompassing electronic health records, sophisticated medical imaging, and intricate genomic sequences, these models promise more accurate diagnostics, significantly more efficient clinical workflows, and the long-anticipated realization of truly personalized patient care.

The real-world integration of solutions like Aidoc’s CARE™ exemplifies this promise, demonstrating tangible improvements in diagnostic speed for critical conditions and streamlining radiologist workflows, validated by crucial FDA clearances. Furthermore, the advent of specialized foundation models like EHRMamba underscores the growing capacity to harness the immense, yet complex, information within electronic health records for predictive analytics and comprehensive clinical decision support. In the realm of genomics, foundation models hold the key to unlocking the full potential of precision medicine, enabling highly individualized risk assessment, therapeutic selection, and drug discovery.

However, the successful and responsible integration of foundation models into the highly regulated and sensitive clinical settings is not without its formidable challenges. Navigating the intricate landscape of data governance, ensuring patient privacy and robust data security, and managing the substantial computational resources required for training and deployment are paramount. Equally critical are the efforts to enhance model interpretability, fostering trust and accountability among healthcare providers and patients alike. Furthermore, proactively identifying and rigorously addressing algorithmic biases is an ethical imperative to prevent the exacerbation of existing healthcare disparities and ensure equitable access to these powerful technologies for all patient populations.

Looking ahead, the future trajectory of foundation models in healthcare hinges on collaborative innovation. This includes the widespread adoption of privacy-preserving techniques such as federated learning, the development of models capable of continuous learning and adaptation to evolving medical knowledge, and sustained, meaningful collaboration between AI developers, healthcare providers, and policymakers. The move towards hybrid AI systems that combine data-driven power with symbolic reasoning, and a unwavering commitment to building AI that is intrinsically trustworthy and ethically sound, will be crucial. By proactively confronting these multifaceted challenges with a shared vision and concerted effort, foundation models can undoubtedly realize their full potential, not merely as technological advancements, but as catalysts for a more intelligent, efficient, equitable, and patient-centric healthcare delivery system for the benefit of global public health.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

References

• Aidoc. (2024). How Foundation Models Are Transforming Clinical AI. Retrieved from aidoc.com
• Aidoc. (2025). Aidoc Secures Landmark FDA Clearance for First Foundation Model-Powered Clinical AI Solution of Its Kind. Retrieved from aidoc.com
• Aidoc. (2025). CARE: Rewriting the Rules of Clinical AI. Retrieved from aidoc.com
• Aidoc. (2025). Aidoc Pioneers Next-Gen AI with CARE1™ Foundation Model, Revolutionizing CT Imaging Standards. Retrieved from aidoc.com
• Aidoc. (2025). The Evolution of Foundation Models in Healthcare. Retrieved from aidoc.com
• Devlin, J., Chang, M. W., Lee, K., & Toutanova, K. (2019). BERT: Pre-training of Deep Bidirectional Transformers for Language Understanding. Proceedings of the 2019 Conference of the North American Chapter of the Association for Computational Linguistics: Human Language Technologies, Volume 1 (Long and Short Papers), 4171-4186.
• Fallahpour, A., Alinoori, M., Ye, W., Cao, X., Afkanpour, A., & Krishnan, A. (2024). EHRMamba: Towards Generalizable and Scalable Foundation Models for Electronic Health Records. arXiv preprint arXiv:2405.14567.
• Li, X., Peng, L., Wang, Y., & Zhang, W. (2024). Open Challenges and Opportunities in Federated Foundation Models Towards Biomedical Healthcare. arXiv preprint arXiv:2405.06784.
• Queiroz, D., Carlos, A., Anjos, A., & Berton, L. (2025). Fair Foundation Models for Medical Image Analysis: Challenges and Perspectives. arXiv preprint arXiv:2502.16841.
• Radford, A., Narasimhan, K., Salimans, T., & Sutskever, I. (2018). Improving Language Understanding by Generative Pre-Training. OpenAI.
• Vaswani, A., Shazeer, N., Parmar, N., Uszkoreit, J., Jones, L., Gomez, A. N., … & Polosukhin, I. (2017). Attention Is All You Need. Advances in Neural Information Processing Systems, 30.
• Wikipedia. (2025). Foundation model. Retrieved from en.wikipedia.org